High-dose acyclovir prophylaxis reduces cytomegalovirus disease in liver transplant patients (Q74106533)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428976%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

High-dose acyclovir prophylaxis reduces cytomegalovirus disease in liver transplant patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428976%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

L Barkholt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428976%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

I Lewensohn-Fuchs

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428976%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B G Ericzon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428976%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

G Tydén

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428976%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Andersson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428976%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428976%20AND%20SRC:MED&resulttype=core&format=json

Transplant Infectious Disease

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428976%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428976%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428976%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

89-97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428976%20AND%20SRC:MED&resulttype=core&format=json

Infectious complications in liver transplantation

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

Clinical patterns of cytomegalovirus disease after liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

Primary and Secondary Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

Risk Factors in the Development of Cytomegalovirus-Related Pneumonia in Renal Transplant Recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

Acyclovir therapy of chickenpox in immunosuppressed children--a collaborative study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

Epstein-Barr Virus Lymphoproliferative Disease Associated with Acquired Immunodeficiency

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

The in vitro activity of Acyclovir and related compounds against cytomegalovirus infections

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

In vitro susceptibility of cytomegalovirus isolates from immunocompromised patients to acyclovir and ganciclovir.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

A Randomized Prospective Trial of Acyclovir and Immune Globulin Prophylaxis in Liver Transplant Recipients Receiving OKT3 Therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

High-Dose Oral Acyclovir Reduces the Incidence of Cytomegalovirus Infection in Liver Transplant Recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

Detection of CMV-matrix pp65 antigen in leucocytes by immunofluorescence as a marker of CMV disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

CMV PCR monitoring in leucocytes of transplant patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

An interchangeable elisa for cytomegalovirus antigen and antibody

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

Clinical use of immunohistopathologic methods for the diagnosis of cytomegalovirus hepatitis in human liver allograft biopsy specimens

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

Polymerase chain reaction for the early diagnosis of cytomegalovirus hepatitis in liver transplant patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

Failure of high-dose oral acyclovir with or without immune globulin to prevent primary cytomegalovirus disease in recipients of solid organ transplants

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

Solid organ transplantation: results and implications of acyclovir use in liver transplants

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010202.X

7 January 2021

10.1034/J.1399-3062.1999.010202.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428976%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428976%20AND%20SRC:MED&resulttype=core&format=json